Mixed Lineage Kinase 2 (MLK2) and vascular homeostasis
Project Number1R03TR004452-01
Contact PI/Project LeaderKANT, SHASHI
Awardee OrganizationBRIGHAM AND WOMEN'S HOSPITAL
Description
Abstract Text
Project Summary
Cardiovascular diseases are among the nation's leading causes of death and disability, with an estimated cost
of more than $351 billion in the USA. Ischemia-induced angiogenesis plays an important role in the recovery of
many vascular diseases. The endothelium plays an even more important role in vascular homeostasis as it
regulates vascular tone, thrombosis, leukocyte trafficking, metabolism, and angiogenesis. Maintaining normal
endothelial function requires balancing numerous physiological and pathophysiological stresses such as shear,
hypoxia, and inflammation. Among the pathways mediating cellular stress, responses are the stress-activated
members of the MAP kinase (MAPK) superfamily, which includes c-Jun N-terminal kinase (JNK) and p38 MAPK.
JNK protein plays an important role in collateral artery formation during development. Recently, we have shown
that neural JNK3 plays a significant role in blood flow recovery after hindlimb ischemia. In probing upstream
components of the MAPK signaling cascade (MAP2K and MAP3K), we found that Mixed Lineage Kinase 2
(MLK2), a MAP3K and upstream regulator of MAPK, is expressed in endothelium and required for normal
postnatal endothelial function. In fact, MLK2-deficient endothelial cells exhibit profound defects in angiogenesis
as well as endothelial proliferation and migration. MLK2 also plays a significant role in VEGF signaling, which is
required for proper endothelium function. RNA-seq data indicates that MLK2-deficient endothelial cells exhibit
both basal and VEGF- induced upregulation of a broadly conserved microRNA, miR-146a, that has previously
been linked to inflammation. Mimics of this miR-146a miRNA administered to wild-type endothelial cells
recapitulate a broad spectrum of the MLK2-deficient phenotype, including defects in proliferation and VEGF
signaling. Using these strategies, we should be able to develop a clear picture of how MLK2 influences
endothelial function and vascular homeostasis. These data will be important as MLK inhibitors are being tested
in the cancer field since very little data is understood regarding their cardiovascular consequences. Moreover,
how Mlk2 influences the vasculature is a large gap in knowledge that we will address.
Public Health Relevance Statement
Cardiovascular diseases are the number one cause of morbidity worldwide, and endothelium
plays an important role in cardiovascular health. This project investigates a pathway known as
Mixed Lineage Kinase 2 and how it impacts the endothelium and is based on our findings that
Mixed Lineage Kinase 2 is needed for normal endothelial function and control signals needed
for new blood vessel formation.
NIH Spending Category
CardiovascularGenetics
Project Terms
ANGPTL2 geneANGPTL4 geneAddressAllelesArteriesBackBlood VesselsBlood flowCardiovascular DiseasesCardiovascular systemCause of DeathCell physiologyCellular StressDataDefectDevelopmentElementsEndothelial CellsEndotheliumExhibitsGene ExpressionGrantHindlimbHomeostasisHypoxiaIn VitroInflammationIschemiaKnock-outKnowledgeLeukocyte TraffickingLinkMAP Kinase ModulesMAPK10 geneMAPK8 geneMalignant NeoplasmsMediatingMetabolismMethodsMicroRNAsMitogen-Activated Protein KinasesMolecularMorbidity - disease rateMusN-terminalNeoplasm MetastasisNeurodegenerative DisordersPathway interactionsPhenotypePhosphotransferasesPhysiologicalPlayProliferatingProtein KinaseRecoveryRoleSignal TransductionStressTestingThrombosisTissue StainsTumor AngiogenesisUp-RegulationVascular DiseasesVascular Endothelial Growth FactorsVascularizationangiogenesisbiological adaptation to stressblood vessel developmentcardiovascular healthclinical developmentcost estimatedisabilityendothelial dysfunctionexperimental studygain of functionin vivoin vivo Modelinhibitorloss of functionmembermigrationmouse modelneuraloverexpressionp38 Mitogen Activated Protein Kinasepostnatalshear stresstranscriptome sequencing
No Sub Projects information available for 1R03TR004452-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03TR004452-01
Patents
No Patents information available for 1R03TR004452-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03TR004452-01
Clinical Studies
No Clinical Studies information available for 1R03TR004452-01
News and More
Related News Releases
No news release information available for 1R03TR004452-01
History
No Historical information available for 1R03TR004452-01
Similar Projects
No Similar Projects information available for 1R03TR004452-01